NEW YORK, November 1, 2022 /PRNewswire/ — The Benign prostatic hyperplasia (BPH) devices market. Size is expected to grow by $3.34 billion from 2021 to 2026. Moreover, according to Technavio, the growth momentum of the market is set to accelerate at a CAGR of 5.09% during the forecast period. The increasing prevalence of BPH coupled with increasing risk factors is driving the market growth of benign prostatic hyperplasia (BPH) devices. However, factors such as the high cost of BPH treatment may challenge the market growth
View a comprehensive report executive summary that describes the market size and forecast along with the research methodology. That FREE sample report is in PDF format
Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Scope
The Benign Prostatic Hyperplasia (BPH) Devices Market report covers the following areas:
Subscribe to our “Basic Plan” is billed annually $5000 This allows you to download 5 reports and view 100 reports per month
Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Segmentation
The Benign Prostatic Hyperplasia (BPH) Devices market is segmented as follows:
The market share growth of Benign Prostatic Hyperplasia (BPH) devices in the TURP segment is expected to be significant during the forecast period. TURP is considered the standard treatment for BPH by many organizations such as the American Urological Association (AMA), the Canadian Urological Association (CUA), and the European Urological Association (EAU). It is efficient, inexpensive, and durable with low long-term complications and repeat treatment rates. The increasing preference for B-TURP for BPH treatment is expected to propel the TURP device segment, which will drive the growth of the targeted market over the forecast years.
- Geography
- North America
- Europe
- Asia
- Rest of the World (SERIES)
37% of market growth comes from North America during the forecast period. The US and Canada are the key markets for benign prostatic hyperplasia (BPH) devices in North America. The growth…
